10-K Decoder · All companies

Nurix Therapeutics, Inc.

NRIX · FY2025 · Fiscal year ended Nov 30, 2025 · 10-K filed Jan 2026

Open the dashboardInfographicSummary

FY2025 key figures

$FY2025FY2024Change
Revenue$84.0M$54.5M+54.0%
Operating income−$286M−$213M−34.1%
Net income−$264M−$194M−36.6%

Latest quarter: Q3 FY2026

Form 10-Q · Three months ended Aug 31, 2026 · filed Oct 13, 2026

$Q3 FY2026Year earlierChange
Revenue$673M$7.90M+8,420%
Operating income$560M−$91.4M
Net income$550M−$86.4M

Q3 FY2026 dashboardQ3 FY2026 infographic

Questions

What was Nurix Therapeutics's revenue in FY2025?
$84.0M in FY2025 (Fiscal year ended Nov 30, 2025), +54.0% vs $54.5M a year earlier, per its 10-K filed Jan 2026.
Was Nurix Therapeutics profitable in FY2025?
No: net income was −$264M and operating income −$286M in FY2025.
What was Nurix Therapeutics's revenue in Q3 FY2026?
$673M (+8,420% vs a year earlier), per its Form 10-Q filed Oct 13, 2026.